There is an inverse relationship between endometriosis and a women's body mass index. To date, the precise mechanisms and aetiological basis linking body mass index with endometriosis remain unknown. Although an increased incidence of endometriosis is observed in women with low body mass indices; endometriosis is associated with conditions common to obesity (hypercholesterolemia, hypertension and coronary heart disease). In the context of endometriosis, further research is necessary in women with surgically confirmed disease to improve clinical advice and patient outcomes.
Multiple studies have reported an inverse relationship between endometriosis and a women's body mass index (BMI), where obesity is associated with a lower incidence of endometriosis. [1] [2] [3] [4] [5] It has been argued that in addition to disease frequency, BMI may also be associated with other endometriosis-related traits. For example, obese women with endometriosis have significantly increased revised American Fertility Society (rAFS) scores, 5 and a higher BMI is linked to increased rates of post-operative recurrence. 6 In Korean women, a lower BMI is associated with increased pain scores 7 and a higher incidence of advanced disease (endometriosis stage III-IV). 8 Not all studies support a correlation between endometriosis and BMI. [9] [10] [11] However, aside from BMI, other anthropometric measures of body composition (i.e. weight, height, skinfold thickness, waist-to-hip ratio, total upper arm area and selfreported body silhouette figures) are also inversely associated with endometriosis. 1, 12, 13 Therefore, a women's body size and adiposity are intertwined into the heterogeneity of endometriosis, but the precise mechanisms and aetiological basis linking a low BMI with endometriosis remain unknown.
Potential reasons for a correlation between endometriosis and a low BMI include that chronic pain can negatively impact on an individual's appetite and that common treatments like nonsteroidal anti-inflammatory drugs can have significant adverse gastrointestinal side effects (i.e. nausea and diarrhoea) which impact negatively on food tolerability. In contrast, it can be argued that the association between a low BMI and endometriosis is illogical; endometriosis is an oestrogen-dependent and inflammatory disorder, and obesity is recognised as being both hyperestrogenic and inflammatory, thus potentially fuelling an environment where endometriosis can flourish. Unlike studies from Western countries, it is intriguing that Taiwanese women with endometriosis have an increased tendency to be obese. 14 One theory is that women with endometriosis who exhibit a low or healthy BMI are in fact metabolically unhealthy or metabolically obese but normal weight. [15] [16] [17] Such metabolic dysfunction among normal-weight women is common, a recent paper examining more than 90,000 women from the Nurses' Health Study reported that 17.1% of normal-weight women are metabolically unhealthy (BMI: 18.5-24.9 kg/m 2 and a report of at least one of hypertension, diabetes or hypercholesterolaemia). 16 A collection of risk factors like hypertension, diabetes or impaired fasting glucose, hypercholesterolaemia or low levels of high-density lipoprotein cholesterol are diagnostic of metabolic syndrome. Metabolic syndrome is more common in women, and oestrogen signalling is suggested to play an important role in its development. 18 Endometriosis is associated with an increased risk of hypercholesterolemia, hypertension and coronary heart disease. 14, 19, 20 Other metabolically-significant co-morbidities have been correlated with endometriosis including deficient thyroid function and abnormal liver metabolism. 14, 21, 22 Some of the hallmarks of poor metabolic health are measurable in young women with endometriosis prior to clinical manifestation, for example, increased arterial stiffness can be identified by age 30, long before the development of atherosclerosis. 23 From a clinical standpoint, if women with endometriosis and a healthy BMI are metabolically unhealthy, this places these women at a heightened risk of associated co-morbidities, and their normal BMI may be masking the phenomenon.
BMI is a simple index of general weight-for-height ratio and has been considered by some to be an inadequate measure of true obesity because it does not consider body shape, regions of adiposity, types of adipose tissue or underlying metabolic disease. Adipose tissue differs in function (including oestrogen production and immunological properties) depending on type and location (subcutaneous or visceral). Endometriosis has been associated with the presence of adipose tissue below the waist (i.e. a smaller waist-to-hip ratio compared to women without endometriosis). 10 Given the potentially dysfunctional metabolic milieu evident in some women with endometriosis, it seems contradictory that pearshaped fat distribution, independent of total body fat, is normally associated with protection against metabolic diseases. 24 A person can have central obesity and still measure a healthy BMI, whereas an accumulation of visceral fat is detrimental to overall metabolic health. 17 While not descriptive of adipose type or location, BMI measurements are a simple, fast and inexpensive clinical tool to record body mass from patients. Following extensive large-scale studies, the utility of BMI remains clinically valuable; for example, BMI is equal to other measures of adiposity (for example, height-to-waist ratios or waist circumference) for predicting risk of poor cardiometabolic outcome, type 2 diabetes mellitus or coronary heart disease. 25, 26 In the context of future endometriosis research, studies should consider distinguishing the amount and distribution of adipose tissue in women, in addition to collecting BMI information. 12 Obesity is a risk factor for metabolic health problems (stroke, diabetes and cardiovascular disease) and cancer. It is well-known that obesity in women and children is on the rise; which impacts the menstrual cycle and timing of puberty. But what is unclear is whether the relationship between BMI and endometriosis is due to cause or effect. The heritability of endometriosis is estimated to be 50%; leaving approximately 50% of disease susceptibly due to environmental influences. While genetic and environmental factors inevitably interact with each other, an individual's BMI can be manipulated by environmental factors or lifestyle choices (including diet, sedentary leisure time and physical activity). Regardless of the presence of endometriosis (or any other pathology), it is important that women maintain a healthy BMI and partake in regular physical activity. In individuals who are metabolically obese but normal weight, increased physical activity improves metabolic health. 17 In the context of endometriosis, further research is necessary to determine what advice can be offered to women regarding changes to lifestyle factors that alter BMI and/or adiposity. Recent work reports that physical activity or sedentary level does not impact on endometriosis. 12 It is internationally recognised that endometriosis research requires 'studies be undertaken to investigate the relationship between phenotypic variables, including BMI and endometriosis'. 27 In the future, population-based longitudinal epidemiological studies are necessary in women with surgically confirmed endometriosis (not self-reported endometriosis) to address the following: can alter the severity of endometriosis (rAFS score) or symptoms of disease (pain score) and/or reduced the incidence of developing poor chronic metabolic health.
The information generated from such studies will improve the potential for translation into evidence-based lifestyle advice for women. This will improve disease management and future screening parameters for women with endometriosis. There remain many unknowns surrounding this common gynaecological disease, and any improvement in understanding this heterogenous and complex disease will improve clinical advice and patient outcomes.
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